Download Files:
Apararenone
SKU
HY-109002-10 mg
Category Reference compound
Tags Metabolic Disease; Cardiovascular Disease, Metabolic Enzyme/Protease;Vitamin D Related/Nuclear Receptor, Mineralocorticoid Receptor
$160 – $950
Products Details
Product Description
– Apararenone (MT-3995) is a novel non-steroidal mineralocorticoid receptor antagonists under development for the treatment of diabetic nephropathies and non-alcoholic steatohepatitis.
Web ID
– HY-109002
Storage Temperature
– -20°C, 3 years; 4°C, 2 years (Powder)
Shipping
– Room Temperature
Applications
– COVID-19-immunoregulation
Molecular Formula
– C17H17FN2O4S
References
– [1]Kolkhof P, et al. 30 YEARS OF THE MINERALOCORTICOID RECEPTOR: Mineralocorticoid receptor antagonists: 60 years of research and development. J Endocrinol. 2017 Jul;234(1):T125-T140.
CAS Number
– 945966-46-1
Molecular Weight
– 364.39
Compound Purity
– 99.09
SMILES
– O=C1N(C2=CC=C(F)C=C2)C3=CC=C(NS(C)(=O)=O)C=C3OC1(C)C
Clinical Information
– Phase 2
Research Area
– Metabolic Disease; Cardiovascular Disease
Solubility
– DMSO : ≥ 125 mg/mL
Target
– Mineralocorticoid Receptor
Pathway
– Metabolic Enzyme/Protease;Vitamin D Related/Nuclear Receptor
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.